Креативная хирургия и онкология (Feb 2017)

HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) IN GASTRIC CANCER (GC) (RESULTS OF THE MULTICENTER CLINICAL TRIAL)

  • H. C. Chung,
  • Y-J. Bang,
  • J. M. Xu,
  • F. Lordick,
  • A. Sawaki,
  • O. Lipatov,
  • M. Lehle,
  • М. Pickl,
  • J. Ruschoff,
  • E. Van Cutsem

DOI
https://doi.org/10.24060/2076-3093-2013-0-4-16-22
Journal volume & issue
Vol. 0, no. 4
pp. 16 – 22

Abstract

Read online

In this article results of the multicenter trial are displayed. Data of successful efficacy of trastuzumab treatment in HER2 positive gastric cancer patients has shown.

Keywords